Literature DB >> 3376989

Hypertension complicating essential thrombocythemia.

J S Bruch1, R S Stein, J A Oates.   

Abstract

Essential thrombocythemia (ET) is a myeloproliferative disorder characterized by marked thrombocytosis with associated hemorrhagic, thrombotic and embolic complications caused by platelet dysfunction. In this report we describe two cases of ET and moderate to severe hypertension associated with renal artery stenosis and renal microvascular lesions. In both cases treatment of the hematologic disorder resulted in reduction of blood pressure and improvement of clinical symptoms.

Entities:  

Mesh:

Year:  1988        PMID: 3376989     DOI: 10.1097/00000441-198805000-00009

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  6 in total

Review 1.  Multiple coronary thrombosis and stent implantation to the subtotally occluded right renal artery in a patient with essential thrombocytosis: a case report with review.

Authors:  Beste Ozben; Ahmet Ekmekci; Zehra Bugra; Sabahattin Umman; Mehmet Meric
Journal:  J Thromb Thrombolysis       Date:  2006-08       Impact factor: 2.300

2.  Cardiovascular Manifestations of Myeloproliferative Disorders: A Review of the Literature.

Authors:  Muhammad Wasif Saif; Umer Khan; Bernard R Greenberg
Journal:  Hosp Physician       Date:  1999-07

3.  Cardiac Complications of Myeloproliferative Disorders.

Authors:  Muhammad Wasif Saif; Umer Khan; Bernard R Greenberg
Journal:  Resid Staff Physician       Date:  2001-07

4.  Erythromelalgia as a presenting manifestation in a patient with essential thrombocythemia complicating renovascular hypertension due to unilateral renal artery stenosis.

Authors:  Jin-Wuk Hur; Young-Yiul Lee; Woong-Soo Lee; Jae-Bum Jun
Journal:  Rheumatol Int       Date:  2005-03-05       Impact factor: 2.631

Review 5.  Renovascular hypertension associated with JAK2 V617F positive myeloproliferative neoplasms treated with angioplasty: 2 cases and literature review.

Authors:  Eikan Mishima; Takehiro Suzuki; Yoichi Takeuchi; Kazumasa Seiji; Noriko Fukuhara; Kei Takase; Hideo Harigae; Takaaki Abe; Sadayoshi Ito
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-14       Impact factor: 3.738

6.  Possible interesting link between Janus kinase 2 mutation and renovascular hypertension.

Authors:  Kouichi Tamura; Kotaro Haruhara; Kengo Azushima; Tamio Iwamoto; Hiromichi Wakui
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-14       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.